You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

97 Results
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
oBINutuzumab,
fludarabine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2021
Statistical Reports
Sep 2016
Statistical Reports
Sep 2016
Cancer facts
Jan 2016
Statistical Reports
Jun 2016
Guidelines and Advice
Status: Current
Jun 2021
Guidelines and Advice
Status: Current
Jun 2021
Guidelines and Advice
Status: Current
Jun 2021
Guidelines and Advice
Status: Current
Jun 2021
Guidelines and Advice
Status: Archived
ID: 20-3
Jan 2016
Guidelines and Advice
Status: Current
ID: 17-4
Version: 2
Nov 2016
Statistical Reports
Jun 2016

Pages